Basiliximab Prophylaxis
Basiliximab Prophylaxis is a monoclonal antibody-based immunosuppressive regimen that selectively targets the interleukin-2 receptor on activated T cells to prevent acute organ rejection in the early post-transplantation period.
13
Publications
403
Citations
80
Authors
24
Institutions
Publications per year
2017–2026
2
Parents
13
Michel Carrier, Marie-Hélène Leblanc, Louis P. Perrault et al. · The Journal of Heart and Lung Transplantation · 2007 · 79 citations
Fu L. Luan, Milagros Samaniego, Mallika Kommareddi et al. · Transplant Infectious Disease · 2010 · 48 citations · Full text
1–5 of 13
80
2
h-index
2
h-index
1
h-index
1
h-index
1
h-index
1–5 of 80
24
Union Hospital
Shatin, China
2 h-index
23 publications
604 citations

Huazhong University of Science and Technology
Wuhan, China
2 h-index
23 publications
604 citations

Hospital Universitario La Paz
Madrid, Spain
1 h-index
1 publications
12 citations

Universidad de Guadalajara
Guadalajara, Mexico
1 h-index
2 publications
22 citations
Mexican Social Security Institute
Mexico City, Mexico
1 h-index
12 publications
132 citations
Kidney Centre
Karachi, Pakistan
1 h-index
5 publications
55 citations
Université de Montréal
Montreal, Canada
1 h-index
4 publications
316 citations
Taihe Hospital
Shiyan, China
1 h-index
1 publications
22 citations
1–8 of 24
4 publications · 44 citations
4
h-index
2 publications · 81 citations
2
h-index
2 publications · 100 citations
2
h-index
1 publications · 17 citations
1
h-index
TCT · 1 publications · 22 citations
1
h-index
1–5